AI Market Mood: Stock Dashboard
ZBIO
Fundamental
Company: Zenas Biopharma Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: Small
Index: RUT
P/E: -
EPS (ttm): -9.10
Insider Own: 49.61%
Shs Outstand: 62.38M
Perf Week: -7.26%
Market Cap: 1.16B
Forward P/E: -
EPS next Y: -4.73
Insider Trans: 1.97%
Shs Float: 31.81M
Perf Month: 4.84%
Enterprise Value: 796.17M
PEG: -
EPS next Q: -1.12
Inst Own: 63.54%
Short Float: 33.60%
Perf Quarter: -30.17%
Income: -425.15M
P/S: -
EPS this Y: 43.01%
Inst Trans: 21.81%
Short Ratio: 16.00
Perf Half Y: -53.84%
Sales: 0.00M
P/B: 3.42
EPS next Y Percentage: 1.66%
ROA: -78.63%
Short Interest: 10.69M
Perf YTD: -49.33%
Book/sh: 5.38
P/C: 1.62
EPS next 5Y: 21.09%
ROE: -137.11%
52W High: 44.60 -58.74%
Perf Year: 84.00%
Cash/sh: 11.36
P/FCF: -
EPS past 3/5Y: -39.47% -
ROIC: -61.93%
52W Low: 8.91 106.51%
Perf 3Y: -
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: -
Volatility W: 5.76%
Volatility M: 7.49%
Perf 5Y: -
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: -128.73%
Oper. Margin: -
ATR (14): 1.36
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 11.94
Sales Y/Y TTM: -100.00%
Profit Margin: -
RSI (14): 45.26
Recom: 1.25
Dividend Gr. 3/5Y: - -
Current Ratio: 11.94
EPS Q/Q: -81.27%
SMA20: -4.43%
Beta: -0.67
Target Price: 42.12
Payout: -
Debt/Eq: 1.05
Sales Q/Q: -100.00%
SMA50: -8.04%
Rel Volume: 1.08
Prev Close: 18.56
Employees: 167
LT Debt/Eq: 1.04
Earnings: May 13 BMO
SMA200: -25.15%
Avg Volume: 667.86K
Price: 18.40
IPO: Sep 13, 2024
Option/Short: Yes / Yes
EPS/Sales Surpr.: 0.96% -
Trades:
Volume: 724,524
Change: -0.86%
Technical:
Latest News:
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 million valuation in US IPO somewhat bullish
ZBIO
Summary: Zenas BioPharma aims for a valuation of up to $689.7 million in its U.S. IPO, backed by Bristol-Myers Squibb and targeting to raise $211.7 million by offering 11.76 million shares.
Full article2024-09-06T12:28:43Z